Endogenous repair after injury in the adult CNS is limited by a number of factors including cellular loss, inflammation, cavitation and glial scarring. Spinal cord neural progenitor cells (SCNPCs) may provide a valuable cellular source for promoting repair following spinal cord injury. SCNPCs are multipotent, can be expanded in vitro, have the capacity to differentiate into CNS cell lineages and are capable of long-term survival following transplantation. Aims & Method: To determine the extent to which SCNPCs may contribute to spinal cord repair SCNPCs isolated from rat fetal spinal cord were expanded ex vivo and transplanted into the adult rat spinal cord after a dorsal column crush lesion. Results: The survival and distribution of transplanted cells were examined at 24 h, 1, 2 and 6 weeks after injury. Transplanted cells were identified at all time points, located mainly at the lesion perimeter, indicating good post-transplant cell survival. Furthermore, SCNPCs maintained their ability to differentiate in vivo, with approximately 40% differentiating into cells with a glial morphology, whilst 8% displayed a neural morphology. Transplanted animals were also assessed on a number of behavioral tasks measuring sensorimotor and proprioceptive function to determine the extent to which SCNPC transplants might attenuate lesioninduced functional deficits. SCNPCs failed to promote significant functional recovery, with a small improvement observed in only one of the four tasks employed, primarily related to improvements in sensory function. Tracing of the corticospinal tract and ascending dorsal column pathway revealed no regeneration of the axons beyond the lesion site. Conclusions: These data indicate that, although transplanted SCNPCs show good survival in the spinal cord injury environment, combination with other treatment strategies is likely to be required for these cells to fully exert their therapeutic potential.
Injury to the adult spinal cord causes cellular loss and the interruption of both ascending and descending spinal tracts. The failure of axons to regenerate results in severe and often permanent functional impairments. Initial traumatic injury is followed by secondary damage, which includes axonal retraction, glial scarring [1] [2] [3] and inflammation [4] [5] [6] . These secondary changes, combined with the presence of axonal growth inhibitors such as those associated with inhibitory CNS myelin [7] [8] [9] [10] and chondroitin sulphate proteoglycans (CSPGs); [11, 12] are thought to inhibit the regenerative capacity of the spinal cord.
Transplantation of various cellular populations has been proposed as a potential strategy for promoting repair in the damaged spinal cord [13] . For example, solid tissue grafts from fetal rat spinal cord have been transplanted into the spinal cord of both newborn and adult rats following complete spinal cord transection, with transplanted animals displaying significant improvements in locomotor function, as well as evidence of growth of axons below the lesion [14, 15] . Olfactory ensheathing cells (OECs) have also been used in transplantation studies. OECs are a particular cellular source that under normal conditions are constantly renewed even in the adult, where they myelinate newly generated olfactory axons [16, 17] . Transplanted OEC's have been found to associate with regenerating axons and promote functional recovery in a variety of injury models in the adult rat [18] [19] [20] [21] . Another source of transplantable cells that may promote repair of the damaged spinal cord are neural progenitor cells (NPCs) [22] . NPCs have been isolated, expanded, and characterized from a number of brain regions including the forebrain, midbrain and spinal cord from developing and adult nervous system tissue [23] [24] [25] [26] [27] . NPCs are multipotent cells that maintain the ability to differentiate into cells of all neural lineages (neurons, oligodendrocytes and astrocytes) in vitro and in vivo [28] ; to self-renew, thus giving rise to new NPCs with similar properties; and to survive implantation when introduced into the developing or degenerating CNS [29] [30] [31] . A number of studies have indicated that NPCs from both the adult and fetal brain can be used as For reprint orders, please contact: reprints@futuremedicine.com transplants following injury to the brain, where they are capable of migration and differentiation into predominantly glial cells but also mature neurons [32, 33] . NPC transplantation has been reported to encourage regrowth of damaged axons and to attenuate the limited regenerative capacity of the CNS [34] . There are a number of potential advantages to NPC transplantation following spinal cord injury. NPC transplants may replace various cell types that are lost following injury [35] . For example, recent studies have shown that following transplantation of 'primed' human NPCs, cholinergic cells with a motorneuron-like appearance were observed in the grafted spinal cord [36, 37] . Furthermore, NPCs transplanted into a primate model of Parkinson's disease were capable of increasing the number of endogenous cells expressing tyrosine hydroxylase [38] . Transplanted NPCs have also been shown to form cellular bridges capable of spanning the lesion and to protect against secondary damage [39] . Transplantation of a multipotent cell population can also allow for the differentiation of cells into several neural cell types, including cells that may promote remyelination [40, 41] . Various transplantation studies have indicated that NPCs can induce remeylination of host axons following injury [42] [43] [44] . NPCs can also secrete trophic factors that may contribute to increased regeneration of axons within the adult spinal cord [45] [46] [47] . A recent study using genetically modifed human NPCs that secrete glial cell line-derived neurotrophic factor (GDNF) indicated good survival and rescue of motor neurons following transplantation in a model of amyotrophic lateral sclerosis [48] .
In the present study, we have used a heterogeneous population of neural stem and progenitor cells cultured from gestational E14 rat spinal cord, which we have termed spinal cord neural progenitor cells (SCNPCs), with the anticipation that they may respond to appropriate cues and factors in the environment of the injured adult spinal cord to promote regeneration of damaged axons and recovery of function. We report that transplanted SCNPCs survived in the local spinal injury environment for at least 6 weeks after transplantation and that while they were able to differentiate into all three CNS cell lineages, approximately half of the transplanted cells remained undifferentiated. Transplantation with SCNPCs revealed minimal attenuation of lesion-induced functional deficits and no axonal regeneration. This study thus demonstrates that SCNPCs can survive and continue to differentiate following transplantation into the injured spinal cord, but that greater restoration of function may be achieved in combination with other therapeutic options.
Methods

Preparation of spinal cord neural progenitor cells
SCNPCs were harvested from the spinal cord of embryonic day 14 (E14) Fischer 344 rat (Harlan) embryos. The spinal cord from the level of the hindbrain to the forelimb was removed from surrounding connective tissue. Trypsin (1 ml 0.25%; Sigma in 3 ml Dulbecco's PBS; Sigma) was added and the cord segments incubated at 37°C (30 min). Growth media (Dulbecco's Modified Eagle's Medium [DMEM]/F12 with N2 supplement-containing insulin (5 µg/ml), human transferrin (100 µg/ml), progesterone (6.3 ng/ml), putrascine (16.1 ng/ml) and selenite (5.2 ng/ml) from Gibco Invitrogen Corporation) was added to the segments (6 ml) and then centrifuged and titrated twice before finally being titrated into single-cell suspension with a fire-polished Pasteur pipette. Cell density was determined by hemocytometric counting. Cells were then seeded into flasks precoated with polyornithine (10 µg/ml) and laminin (10 µg/ml) at a density of 2 × 10 5 cells per 75 cm 2 flask and incubated at 37°C in humidified 5% CO 2 /95% air atmosphere. DMEM/F12 with N2 + FGF-2 (20 ng/ml from PeproTechEC) was changed every 3 days. Cells were expanded until they reached 70-80% confluency. They were gently removed from the flask surface with trypsin (1 ml 0.25%), centrifuged and triturated twice before finally being titurated into single-cell suspension with a fire-polished Pasteur pipette and re-seeded at 2 × 10 5 cells per 75 cm 2 flask . This was performed no more than three times prior to harvesting for transplantation. Multipotency of expanded SCNPCs was confirmed by examining sister cultures seeded at 3 × 10 4 cells on with polyornithine (10 µg/ml) and laminin (10 µg/ml) coated glass coverslips. DMEM/F12 with N2 and FGF-2 was removed and replaced with DMEM/F-12 containing a combination of alltrans retinoic acid (1 µM, Sigma) and dibutyl cAMP (1 µM, Sigma) for 3 days.
Labeling spinal cord stem cells
SCNPCs were labeled with bromodeoxyuridine (BrdU), which uses nucleotide substitution to replace a thymidine with uridine in newly synthesized DNA (Gage, 2000) . Cells were incu-future science group future science group www.futuremedicine.com bated in BrdU (10 µg/ml in FGF-2 medium) for 48 h prior to harvesting for transplantation. For transplantation, the cells were gently removed from the flasks with trypsin (1 ml 0.25% in 3 ml Dulbecco's PBS). Cells were then centrifuged and triturated twice before finally being titurated into single-cell suspension with a fire-polished Pasteur pipette. Cells were concentrated to 7.5 × 10 4 cell/µl in FGF-2 containing media and placed on ice in preparation for grafting.
Lesion surgery & transplantation
The care and treatment of the animals was in accordance with UK Home Office regulations. Adult male Fischer 344 rats (200-220 g, Harlan) received a spinal cord injury and transplants of SCNPCs (n = 16). Vehicle control groups received injections of FGF-2 medium (n = 16) or were sham lesioned (n = 10). Two animals from the SCNPC and vehicle control group and one sham were sacrificed at each of four time points (24 hr, 1 week, 2 weeks and 6 weeks postlesioning), for histological analysis of transplanted cells and other endogenous markers. Eight animals per treatment group were assessed for functional recovery and then used for anatomical tracing studies.
Surgical procedures were performed under ketamine (0.60 mg/kg) and medetomidine (0.25 mg/kg) reversible anaesthesia with sterile precautions. During surgery, animals were placed on a heating blanket to maintain body temperature. Surgical procedures have been described previously [49] . Briefly, a partial laminectomy was performed at C4 and lignocaine (2%, Antigen Pharmaceuticals, Roscrea, Ireland) was applied to the exposed spinal cord. The dura was removed to expose the dorsal columns, which were then crushed with fine watchmakers' forceps. The tips of the forceps were positioned on either side of the dorsal columns, pushed 2 mm down into the cord then held together for 10 s before raising them back out of the cord. A micropulled pipette connected to a Hamilton syringe was used to inject 2 µl of vehicle control or 2 µl of SCNPC suspension directly into the core of the lesion site and also to sites 1mm rostral and caudal to the lesion, with all injections at a depth of 2 mm from the dorsal surface, and performed over a 2 min infusion period. Approximately 150,000 BrdU-labeled cells were injected at each site. The microneedle was kept in situ for 2 min following injection then raised 1 mm for a further minute before gradually being removed from the spinal cord. The viability of the remaining cells in suspension was checked at the end of surgery using Trypan blue exclusion. Trypan blue (Sigma) was added to cell suspensions (total 1 ml) and total cells and unstained cells were counted with a hemocytometer. The number of live cells in the cell preparation at the end of transplantation surgery was found to be approximately 85%. Sham-lesioned animals were anaesthetized and the dorsal vertebrae exposed but no laminectomy or spinal injury was performed. The muscle and skin layers were sutured and a 4 ml bolus injection of saline was injected subcutaneously in each rat.
Behavioral analysis
To assess whether transplantation of SCNPCs improved sensory and motor function, a series of behavioral tasks were performed. Prior to surgery, all rats were trained every 3 days on each of the tasks for 2 weeks and baseline readings taken prior to surgery. Performance in each of the behavioral tasks was assessed 2 days after surgery, followed by testing once a week for a further 6 weeks.
The tape removal test was used to assess sensorimotor performance following spinal cord injury [50] . A small piece of adhesive tape (∼0.3 × 2.0 cm) was placed onto each forepaw in turn and the time taken to successfully remove the tape was then determined. Other sensorimotor tasks were also examined [51] . Rats were trained to cross a narrow wooden beam (2.5 cm × 90 cm), a wire grid (20 cm × 75 cm with 2.5 cm × 2.5 cm grid squares) and a wire ladder (20 cm x 75 cm with 3 cm spacing between each rung). Forepaw slips were recorded (determined by a paw slipping off the beam or below the plane of the grid), and right and left forepaw scores were averaged as no differences were noted between them.
Retrograde & anterograde neuronal tracing
At 6 weeks postlesion, animals were anaesthetised and 1 µl biotin dextran amine (BDA) (Molecular Probes; 10KDa, 10% in phosphatebuffered saline [PBS]) was injected into 12 sites over the primary motor cortex approximately 1 mm below the dorsal surface of the brain in order to label the descending corticospinal tract axons using established stereotaxic coordinates [52] . At 9 weeks postlesion rats were again anaesthetised and the sciatic nerve was exposed. A small incision was made in the epineurium, and
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future science group future science group a 10 µl Hamilton syringe with a glass pulled pipette was inserted through the epineurial incision. A total of 4 µl of a 1% cholera toxin B subunit solution (CTB; in ddH 2 O; List Biological Laboratories, CA, USA) was injected. The syringe was removed and the incision was sutured. This procedure was performed on both hindlimbs. Animals were sacrificed and perfused 1 week later (10 weeks postlesion) and analyzed as described below.
Immunocytochemistry
To examine the cellular phenotype of SCNPCs and their differentiated progeny, cultures of proliferating, differentiated and BrdU-labeled SCNPCs were examined using immunocytochemistry and antibodies for specific neural cell types [53] . Briefly, in vitro SCNPCs fixed with 4% paraformaldehyde (PFA) were washed in trishydroxymethylaminomethane (TRIS) buffered saline (50mM Tris(hydroxymethyl) methylamine plus 150mM NaCl pH 7.4) (TBS) several times followed by incubation in 3%H 2 O 2 in TBS for 30 min. Cells were then incubated in 5% milk in 0.1% Triton X-100/TBS (TBS+) for 30 min to reduced nonspecific primary antibody binding. The cells were then incubated in either monoclonal antinestin (1:100; developmental studies hybridoma bank [DSHB], Iowa University, IA, USA), monoclonal anti-BrdU (1:100; Amersham Biosciences), monoclonal anti-RIP (oligodendrocytes, 1:100; DSHB), monoclonal anti-β-III tubulin (neurons, 1:1000; Sigma-Aldrich) or polyclonal rabbit anti-glial fibrillary acidic protein (GFAP) (astrocytes, 1:1000; DAKO, Glostrup, Denmark) overnight at 4°C. The following day after extensive washing, the cells were incubated with either antimouse horseradish peroxidase (HRP) conjugated antibody (1:250; Vector Labs) or antirabbit HRP conjugated antibody (1:200; Vector Labs) for 1 h at room temperature and visualized using diaminobenzidine (Vector Labs) for 3-8 min.
Immunohistochemistry
Following various postlesion survival times, rats were given an overdose of sodium pentobarbital (80 mg/kg intraperitoneal) and perfused transcardially with 0.1 M PBS followed by 4% paraformaldehyde in 0.1 M PBS (pH 7.4). The spinal cords were then removed and split into cervical (including lesion), cervical (caudal to lesion) and lumbar segments. They were embedded in 10% gelatin (Sigma-Aldrich) and sagitally sectioned at 35 µm using a Vibratome™ (Leica). Sections were then incubated through a series of acids (10 min at 1N HCl on ice, 10 min at 2N HCl room temperature, then a further 20 min at 37°C) before incubating with 0.1M borate buffer for 12 min. Further washes in PBS were performed before an incubation step in PBS+-Glycine (1M)+5% normal goat serum (1h) prior to incubating overnight (r.t) with either anti-BrdU (1:100) alone or for doublelabeling experiments with anti-BrdU and either biotinylated NeuN (1:200; Chemicon), polyclonal rabbit anti-GFAP (1:7000; DAKO), polyclonal rabbit anti-NG2 (1:200, Chemicon), biotinylated nestin (Neuromics) or polyclonal goat anti-CTB (1:1000; List Biological Laboratories) in PBS+0.1% TritonX-100. Sections were then washed in PBS + 0.1% TritonX-100, then incubated (4 h at r.t) with either CY3 conjugated rabbit antimouse (1:400; Jackson ImmunoResearch, PA) or fluorescein-conjugated mouse antirabbit (1:200; Jackson ImmunoResearch, PA) secondary antibodies. Where the primary antibody was conjugated with biotin, extra-avidin fluorescein isothiocyanate (FITC) (1:400; Jackson ImmunoResearch, PA) was applied. Sections were washed in PBS and mounted onto glass coverslips using vectorshield (Vector Labs). To ensure that a complete lesion of the dorsal columns at C4 had been achieved, lumbar tissue embedded in gelatin was cut transversely and processed for PKCγ immunocytochemistry [54] . Tissue was processed as above and incubated with PKCγ (1:400; Santa Cruz) overnight prior to further washes and incubation with fluorescein-conjugated donkey antirabbit (1:200; Jackson ImmunoResearch, PA). To identify BDAlabeled axons, tissue was washed and incubated immediately with extra-avidin FITC (1:400; Jackson ImmunoResearch, PA) before being mounted onto glass coverslips using vectorshield (Vector Labs).
Image analysis
The cells were visualized under a Zeiss Axioplan 2 imaging microscope running the Axiovision 3.1 image analysis software. For in vivo cell counts, five tissue sections from each animal were selected laterally through the spinal cord at equal distances from the centre section. Sections of cord 3 mm in length with the lesion site in the centre were selected for analysis. A total of 35 images were obtained per section approximately every 200 µm in five rows and the number of BrdU-positive cells were counted. An average was then taken of animals within a treat-future science group future science group www.futuremedicine.com ment group to generate a pattern of where the cells were located through the spinal cord following transplantation. To obtain an indication of the differentiation pattern of transplanted cells, the total number of cells that were BrdUpositive were counted in each image followed by the number of cells that were positive both for BrdU and a cell-specific antigen.
Statistics
Effects of treatment on behavioral function were analyses using a two-way repeated measures (RM) analysis of variance (ANOVA, groups × days). Post-hoc comparisons were made using the Tukey post hoc test (SPSS, USA). p < 0.05 taken as significant.
Results
In vitro differentiation & labeling
In vitro, in the presence of FGF-2, SCNPCs proliferated rapidly. Most proliferating SCNPCs (passage 1-3) were shown to express high levels of nestin, an intermediate filament protein marker that identifies neural stem cells in an undifferentiated state ( Figure 1A ). These undifferentiated SCNPCs have a typical roundshaped cell body morphology with multiple small processes. The multipotency of expanded SCNPCs was confirmed by examining sister cultures differentiated for 3 days with a combination of all-trans retinoic acid (1 µM) and dibutyl cAMP (1 µM) for expression of proteins characteristic of neurons, astrocytes and oligodendrocytes. Following this differentiation protocol, cells showing typical morphology and expressing RIP (oligodendrocytes, Figure 1B ), β-III tubulin (neurons Figure 1C) and GFAP (astrocytes Figure 1E) were identified in vitro. Based on these data the SCNPCs isolated from the rat fetal spinal cord are capable of proliferation and differentiation into all three cell lineages of the CNS and thus fulfil the criteria of SCNPCs.
Survival & migration following transplantation
We examined whether SCNPCs isolated from the developing spinal cord could survive, migrate and differentiate after transplantation into the lesioned adult spinal cord. SCNPCs exposed to BrdU were identified by a nuclear stain which revealed that approximately 95% of all cells expressed detectable levels of BrdU after 48 h of exposure (Figure 1E ), prior to transplantation.
The survival of transplanted SCNPCs in vivo was assessed using anti-BrdU immunocytochemistry. Examination of sagittal sections from all postinjury time points identified nuclei stained with anti-BrdU surrounding the lesion site. Figure 2 shows an example of BrdU-labeled cells at 1 week post-transplantation, with BrdU-positive SCNPCs clearly visible as small nuclei around the lesion perimeter and in the surrounding gray and white matter (Figure 2B-C) . BrdU-positive SCNPCs were also evident at rostro-caudal sites extending from the lesion site, presumably from the transplantation sites distal to the lesion ( Figure 2B ). SCNPCs were also identified at least 4 mm away from the lesion site with BrdU-positive cells evident in the central canal; possibly suggesting active and passive dispersion from the injection sites and lesion ( Figure 2B) . A similar pattern of BrdU-labeled cells was identified at all time points analyses (24 h, 1 week, 2 weeks and 6 weeks) following transplantation. To quantify the numbers and distribution patterns of the transplanted SCNPCs, extensive analysis of grafted cells was performed at 1, 2, and 6 weeks posttransplantation (schematic, Figure 3D ). Following transplantation, most BrdU-positive cells were located close to the epicentre of the lesion at all time points, represented by the peaks around the zero point (with point zero representing the lesion epicentre, Figure 3A-C) . Grafted SCNPCs were also observed at sites distal to the lesion site (3 mm) ( Figure 3A-C) , most likely from cells transplanted at sites caudal and rostral to the lesion. However, there were fewer BrdU-positive cells further from the lesion, suggesting that following transplantation many of the cells are attracted towards the lesion site. Total cell numbers showed that 3.3 × 10 5 (± 8 × 10 4 ) SCNPCs were present at least 1 week following transplantation. In subsequent weeks the total number of transplanted SCNPCs declined to approximately 2.0 × 10 5 (± 7 × 10 4 ) and 1.5 × 10 5 (± 8 × 10 4 ) cells at 2 and 6 weeks, respectively.
Differentiation of SCNPCs after transplantation into the lesioned spinal cord
We have demonstrated in vitro that SCNPCs obtained from the fetal rat spinal cord have the ability, when given the correct cues, to differentiate into the three main cell types of the CNS (Figure 1A-D) . Antisera specific for CNS antigens delineating the three major CNS cell populations were also used to determine whether SCNPCs retain this differentiation capability 
Assessment of functional recovery following transplantation of SCNPCs into the lesioned spinal cord
A number of behavioral tests were used to assess whether transplantation of SCNPCs were capable of improving sensorimotor functions. Two days postlesion the SCNPC group and the vehicle control group showed a significant increase in the number of forepaw slips on the beam, grid and ladder sensorimotor tests compared with sham-lesioned animals (two-way RM ANOVA, p <0.05; Tukey, p < 0.05; Figure 5A -C). Following this initial increase in forepaw slips there was a general trend in all lesioned animals towards recovery in the three tasks over time (Figure 5A-C) . There was, however, no significant improvement in these tasks at any time point between the SCNPC transplant group compared with the vehicle control group (Tukey, p >0.05, two-way RM ANOVA; Figure 5A -C). In the tape removal test there was a significant increase in the amount of time taken to remove the adhesive tape from the forepaws between groups (two-way RM ANOVA, p < 0.05) with both lesioned groups severely impaired in this task at early postlesion time-points. However, some recovery on this task was observed in the SCNPC transplanted group, with a significant improvement in performance observed at 28 and 35 days posttransplant compared with the vehicle controls, with SCNPC grafted animals showing an improved ability to remove the tape, suggestive of improved sensory function (Tukey, p < 0.05; Figure 5D ). By 40 days postlesion, however, there was no significant difference in performance between the SCNPC transplanted animals and vehicle-treated controls ( Figure 5D ).
Assessment of axon regeneration following transplantation of SCNPCs into the lesioned spinal cord
To confirm a complete lesion of the corticospinal tract (CST) following dorsal column crush injury, lumbar sections of spinal cord were stained with PKC-γ, an immunoreactive marker for the CST [55, 56] . The dorsal columns and lamina II of the dorsal horns of sham animals displayed intense PKC-γ immunoreactivity ( Figure 6A) . However, in all of the vehicle control and SCNPC-transplanted animals there was a complete loss of PKC-γ staining within the dorsal columns following the crush injury, indicating complete transection of the CST (Figure 6B ). Prior to termination, the descending CST was labeled with the tracer BDA. In sham control animals BDA-labeled CST axons were clearly visible descending from the rostral spinal cord ( Figure 6C) . In lesioned animals treated with vehicle control, BDA-labeled axons were observed rostral to the injury site but these axons halted at the lesion site, with no fibres observed crossing to the caudal side of the lesion (Figure 6D & F) . A similar pattern of BDA tracing was seen in the SCNPC transplant animals, with most BDAlabeled CST axons observed rostral to the injury site and not traversing to the caudal side of the injury site (Figure 6E & G) . The ascending hindlimb dorsal column projection was also labeled with the tracer CTB. Analysis of lumbar spinal cord sections confirmed accurate uptake of the CTB tracer, with CTB immunostaining revealing labeling of primary afferent terminals in the dorsal horn and ventral horn motorneurons (Figure 7A-B) . In the cervical spinal cord, at the level of the lesion site, CTB-labeled axons were Beam, grid and ladder sensorimotor tests performed after a C4 dorsal column crush injury showed impairments at early time points postinjury, but recovery over time was observed in both the vehicle and SCNPC transplanted groups, with no significant differences between the two. The tape removal task also revealed impairments in both injury groups at early time points and a significant difference was observed (p <0.05, two-way RM ANOVA) at 28 and 35 days following injury, with SCNPC transplanted animals being able to remove the tape more rapidly than vehicle-treated animals. However, by 45 days postinjury the improvement was no longer apparent, indicating that recovery in the SCNPC transplanted animals was limited. RM ANOVA: Repeated measures analysis of variance; SCNPC: Spinal cord neural progenitor cells. observed caudal to the lesion site, but no fibers were observed crossing to the rostral side of the lesion in animals treated with a vehicle control (Figure 7C & E) . A similar pattern of CTB tracing was observed in the SCNPC transplanted animals, with numerous CTB-labeled axons with growth cone-like endings observed at the caudal edge of the lesion but not traversing the lesion site ( Figure 7D & F) . This suggests that the SCNPC transplants, as a single treatment, do not induce significant regeneration of damaged axons through and beyond the lesion.
Discussion
In this study, we demonstrate first that SCNPCs can be isolated from the developing rat spinal cord and that in vitro they proliferate readily and differentiate into all three CNS cell lineages. Furthermore, we demonstrate that SCNPCs are capable of long-term survival following transplantation into the lesioned adult spinal cord, and that following transplantation they retained the ability to differentiate into the CNS cell lineages. However, we found that acute transplantation of SCNPCs into the lesioned adult spinal cord did not lead to significant improvements in behavioral function or regeneration of severed ascending and descending axons. Potential therapeutic benefit from transplantation of SCNPCs in spinal cord injury may be derived in a number of different ways including cellular replacement of damaged and lost cells [37] , the potential formation of synaptic relays and cellular bridges [57] , remyelination of damaged axons [58] and secretion of neurotrophic factors that may support damaged cells [59] . Most importantly, SCNPCs have the potential to differentiate into all the cell types of the CNS and could therefore repopulate specific cell types that are lost following spinal cord injury. In our study we were able to identify transplanted neural stem cells that had differentiated into astrocytes (26 ± 8.8%), oligodendrocyte precursors (18 ± 6.4%) and neurons (6.1 ± 1.1%) 6 weeks following transplantation into the adult spinal cord. However, approximately 50% of the grafted cells appeared to remain undifferentiated at this time point. Previous examination of NPC sources following spinal cord injury has indicated good survival. However, analysis of differentiation post-transplantation has generally been qualitative. For example Chow et al. only identifying neuronal differentiation following Brain-derived neurotrophic factor (BDNF) enrichment of the injury site [60, 61] . Similarly, Lepore and Fischer (2005) observed semiquantitatively that the transplanted cells differentiated into neurons and glia, but interestingly they identified few immature cells remaining at 3 weeks [52] . demonstrated that most transplanted NPCs remained undifferentiated when examined 5 weeks following a delayed transplant into the contused spinal cord, with astrocytes (32.6%), In control lumbar spinal cord, PKCγ immunoreactivity is present in the dorsal horn and the CST (A). After a dorsal column lesion, PKCγ immunoreactivity is no longer present in the CST (arrows in A & B) , confirming a complete CST lesion. In sham control animals BDA-labeled CST axon terminals were observed in gray matter in the cervical spinal cord of sham animals (C). In lesioned animals BDAlabeled CST fibres are not observed caudal to the injury site following vehicle injections (D & F) . A similar pattern of BDA-labeled axons are seen in the SCNPC transplanted animals, with fibres observed at the rostral border of the lesion site, but none extending into or beyond (E & G). Scale: A-B, 500 µm: C-E, 500 µm; F-G, 150 µm. BDA: Biotin dextran amine; CST: Corticospinal tract.
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future science group future science group neurons (5.9%) and oligodendrocytes (4.4%) making up a small proportion of the grafted cells [62] . In agreement with the present study, most reports of NPC transplantation into the damaged spinal cord have described a preferential differentiation of transplanted cells towards a glial cell fate [63] [64] [65] [66] . For example, when neuronalrestricted NPCs were engrafted into the contused spinal cord, most of the cells differentiated into cells with a glial phenotype (>50%) with less than 16% remaining undifferentiated 2 months after transplantation [67] . In a separate study, NPCs grafted into the intact neonate spinal cord were capable of differentiation. However, they predominantly differentiated into oligodendrocytes or astrocytes depending on whether they were derived from the fetal hippocampus or spinal cord, respectively, and neuronal differentiation remained very low [68] . Although recent studies have shown that astrocytes may have a beneficial role within the injured spinal cord [69, 70] , reactive astrocytes are generally considered to limit the extent of regeneration that can occur following spinal cord injury in the adult.
In the present study we find that neuronal differentiation of transplanted SCNPCs is more substantial after 6 weeks than some other studies have found, and second, whilst transplanted SCNPCs do differentiate predominantly into astrocytes (26%) and oligodendrocytes (17%), albeit at levels that are lower than previous studies, the remaining 50% of the transplanted cells appear to remain undifferentiated. This may be advantageous in that the differentiation pattern of grafted cells could potentially be modulated by the application of various growth factors or compounds to the cells prior to, or following, transplantation, which may induce differentiation into particular neural phenotypes. For example, the application of agonists specific for each of the retinoid receptors significantly modulates the number of spinal cord motor neurons generated by SCNPCs ex vivo [71] , which could be exploited for biasing neural differentiation prior to transplantation. Hofstetter and colleagues transduced NPCs with Ngn2 to promote significantly greater neural differentiation following transplantation into the lesioned spinal cord [72] . A recent study by Cao and co-workers (2005) used glialrestricted progenitor cells (GRPs) to express the multineurotrophin D15A following contusion injury. Expression of D15A by transplanted GRPs significantly increased oligodendrocyte differentiation, leading to increased myelin formation and recovery of both electrophysiological and hindlimb locomotion [73] . There is also the possibility of using gene transfer to introduce trophic factor genes into NPCs. For example, transfection with neurotrophin-3 has been found not to affect the normal differentiation pattern of NPCs whilst maintaining a high expression level following transplantation into the adult spinal cord [74] . Thus, the ability to manipulate NPCs can allow particular cellular phenotypes to be produced and selective trophic factors to be codelivered, which have the potential to be targeted to particular lesion pathologies.
Following injury, cellular migration may be required for CNS axonal regeneration, allowing the cells to move through the cord to reach retracted axons, where they may provide trophic and other neuroprotective factors to damaged neurons, as well as promoting the remyelination of damaged axons, thus enhancing the regenerative response. In the present study we provide evidence that transplanted SCNPCs, although predominantly remaining around the lesion site, are capable of diffusion at least 4 mm caudal and rostral from the site of implantation. Our observations appear consistent with other NPC transplantation studies, where migration seems to vary between 2-8 mm [75] [76] [77] . The migratory capabilities of the SCNPCs may also account for lower cell numbers seen at the later time points as a number of migrated SCNPCs may have been outside the areas selected for distribution analysis. The integration of transplanted cells into the host spinal cord tissue following injury suggests that SCNPCs from the developing spinal cord may be useful in delivering growth or neuroprotective factors to promote neuroprotection and regeneration in focal injury. This may be enhanced by pretransplantation manipulation or gene therapy to deliver growth factors to both the injury site and surrounding regions. Importantly, following transplantation into host tissue our SCNPCs do not generate tumors within the spinal cord of the adult rats.
The ascending and descending projections within the dorsal column are important for discriminative touch and proprioception as well as skilled motor function. Thus, a lesion to this region results in sensory and motor deficits of forepaw function [78] . The sensorimotor behavioral tasks selected in the present study required accurate limb placement and motor coordination to successfully navigate across the ladder, beam and grid, and sensory awareness and motor coordination to remove the tape. We have demonstrated that transplanted SCNPCs did not promote robust improvements in functional recovery, with only a slight improvement observed in the tape removal task following transplantation into the lesioned spinal cord. This improvement only became significant 28 days after injury. Interestingly, previous studies that have shown only modest functional improvements following cellular transplantation into the lesioned spinal cord, observe that these improvements do not become manifest until at least 2 weeks after transplantation [79] [80] [81] [82] . For example, reported significant differences in pellet retrieval tasks between control and treatment groups which first appeared 44 days after injury [83] . There are a number of possible explanations for delayed functional recovery following SCNPC transplantation, one of which may be the integration and formation of connections between transplanted SCNPCs and the host system. The SCNPCs may also require time to generate enough neurotrophic support for the surrounding host tissue following transplantation. Another possibility is the contribution of the SCNPCs to production of myelin, in particular donor derived oligodendrocytes have the ability to remyelinate fibers that have been demyelinated and spared following injury [84] [85] [86] . Evidence from in vitro data suggests that NPCs and the conditioned media they produce are capable of promoting CST growth [87] . However, it is clear that this represents a very different environment to the injured spinal cord. In vivo, GRP cells transplanted following contusion injury continue to differentiate into oligodendrocytes and astrocytes and are capable of modulating the lesion environment, reducing astrocytic scarring and proteoglycan expression [88] . However, although alterations in CST axon morphology were observed, there was limited axonal regeneration.
Many of the differences observed in functional outcomes and anatomical regeneration between our study and others in the literature could be associated with the different cellular sources, timing of transplantation and lesion paradigms utilized. Furthermore, although alternative cellular sources have been observed to result in improvement of functional outcomes [89, 90] , much like the NPC transplantation studies they often fail to correlate the functional recovery with anatomical regeneration, making it unclear whether the transplant is the sole reason for functional recovery. However, there has been a recent study that observed the sparing and sprouting of pathways such as serotonergic and noradrenergic fibers following transplantation of a mixture of neuronal restricted precursors (NRPs) and GRPs into the contused adult spinal cord [91] . This sparing was accompanied by improved bladder and motor function and decreasing thermal hypersensitivity [92] .
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Conclusion
This study has shown that SCNPCs derived from fetal rat spinal cord are capable of maintaining typical 'stem cell' properties in vitro. Following transplantation into the lesioned adult rat spinal cord they survive for at least 6 weeks, migrate and maintain the ability to differentiate into the three main CNS cell lineages. However, no robust recovery in behavioral function or significant axonal regeneration was observed. This study highlights some of the caveats that need to be considered when choosing the injury model, cellular population and timing of transplantation. With many alternative cellular sources and injury models being used it is difficult to clearly delineate which source would be most appropriate for clinical translation. The difference in functional recovery between the present study and previous studies may be owing to a number of variations in experimental design and highlights the significant variability that accompanies cellular transplantation studies. Furthermore, although improvements in motor function have recently been observed following NPC transplantation, this was also accompanied with aberrant axonal sprouting and allodynia in the forepaws, suggesting that caution be taken when interpreting results from transplantation studies [93] . Additional studies will be required to examine whether improved axonal regeneration and greater functional recovery can be achieved with SCNPC transplants when combined with other repair strategies, such as natural scaffolds [94, 95] , artificial polymers [96, 97] , neurotrophic factors [98, 99] , degrading inhibitory CSPGs [100] [101] [102] or neutralizing inhibitory CNS myelin [103] [104] [105] [106] . Huber AB, Weinmann O, Brosamle C, Oertle T, Schwab ME: Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS
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Executive summary
• Spinal cord neural progenitor cells (SCNPCs) are capable of long-term survival following transplantation into the lesioned adult spinal cord.
• Following transplantation the SCNPCs retain the ability to differentiate.
• Acute transplantation of SCNPCs into the lesioned adult spinal cord did not lead to significant improvements in behavioral function or regeneration of severed ascending and descending axons.
• Difference between work presented here and previous studies highlight the variations in experimental design and the variability that accompanies cellular therapy.
• Highlighted a number of key decisions that need to be considered when delivering a cell source to lesioned animal models, including timing and cellular population.
• Important to examine what the undifferentiated cells are capable of doing, thus a future experiment would be to stimulate either prior to transplantation or upon delivery of the cells to the lesioned spinal cord and encourage differentiation of this population of cells.
• Future experiments would include the use of SCNPCs in combination with other proven strategies including degrading inhibitory chondroitin sulphate proteoglycans (CSPGs) and environmental enrichment to enhance plasticity.
